(2015.11.27)The discovery and clinical development of AZD3759, a potent, selective, oral active, CNS penetrant EGFR inhibitor

   

Dear All:

Institute of Molecular Medicine
Research Seminar


 

TitleThe discovery and clinical development of AZD3759, a potent, selective, oral active, CNS penetrant EGFR inhibitor

SpeakerXiaolin Zhang, Ph.D. 

                 Vice President and Head of AstraZeneca Asia Research and Early Development

Time
2015
1127日(星期五)上午10:00-11:00

Place:北京大学英杰交流中心306会议室

Host:北京大学分子医学研究所       肖瑞平(Tel. 6276-0700)